Low-dose naltrexone and fibromyalgia

In my training as a physical therapist, pharmacology was required study.
Traditional physical therapy comes in contact with many different
medications for pain, inflammation, etc. As I began my Myofascial
Release training, medications were viewed as maskers of symptoms and
frowned upon.

Research published earlier this year shed light on a promising new treatment partner for fibromyalgia sufferers. Low-dose
naltrexone has shown to be effective in reducing the symptoms (pain) of
fibromyalgia. Published in 2009 by the scientific journal Pain Medicine,
low-dose naltrexone produced a 30% reduction in symptoms vs use of a
placebo. Given the very low side effects of this compounded medication,
it merits inclusion into the treatment choices of fibromyalgia
sufferers. Low-dose naltrexone is not a pain medication. It affects the
body in different ways. You can read the full text version of this
research paper on my website (#229).

How do you feel about studies such as these?

Walt Fritz, PT
www.MyofascialResource.com